Janney Montgomery Scott’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-42,915
| Closed | -$146K | – | 2132 |
|
|
2018
Q3 | $146K | Buy |
42,915
+7,150
| +20% | +$24.3K | ﹤0.01% | 1962 |
|
|
2018
Q2 | $134K | Sell |
35,765
-47,150
| -57% | -$177K | ﹤0.01% | 1916 |
|
|
2018
Q1 | $339K | Sell |
82,915
-7,800
| -9% | -$31.9K | ﹤0.01% | 1544 |
|
|
2017
Q4 | $422K | Buy |
90,715
+14,800
| +19% | +$68.8K | ﹤0.01% | 1400 |
|
|
2017
Q3 | $539K | Sell |
75,915
-650
| -0.8% | -$4.62K | 0.01% | 1221 |
|
|
2017
Q2 | $554K | Buy |
76,565
+10,000
| +15% | +$72.4K | 0.01% | 1133 |
|
|
2017
Q1 | $410K | Buy |
66,565
+15,000
| +29% | +$92.4K | 0.01% | 1253 |
|
|
2016
Q4 | $302K | Buy |
51,565
+50
| +0.1% | +$293 | ﹤0.01% | 1327 |
|
|
2016
Q3 | $274K | Sell |
51,515
-31,015
| -38% | -$165K | ﹤0.01% | 1234 |
|
|
2016
Q2 | $546K | Buy |
82,530
+40,215
| +95% | +$266K | 0.01% | 513 |
|
|
2016
Q1 | $198K | Sell |
42,315
-629
| -1% | -$2.94K | 0.01% | 1150 |
|
|
2015
Q4 | $217K | Sell |
42,944
-471
| -1% | -$2.38K | 0.01% | 1190 |
|
|
2015
Q3 | $153K | Buy |
43,415
+16,950
| +64% | +$59.7K | ﹤0.01% | 1305 |
|
|
2015
Q2 | $264K | Sell |
26,465
-6,800
| -20% | -$67.9K | 0.01% | 1586 |
|
|
2015
Q1 | $423K | Buy |
33,265
+3,200
| +11% | +$40.7K | 0.01% | 1495 |
|
|
2014
Q4 | $425K | Buy |
30,065
+8,200
| +38% | +$116K | 0.01% | 1428 |
|
|
2014
Q3 | $301K | Buy |
21,865
+8,050
| +58% | +$111K | 0.01% | 1657 |
|
|
2014
Q2 | $212K | Buy |
+13,815
| New | +$212K | ﹤0.01% | 1908 |
|